The MRF Welcomes Susan Vogel
October 30, 2020In October 2020, the Melanoma Research Foundation welcomed Susan Vogel to the MRF team as Chief Development Officer. Susan was previously the executive director of the Charles Regional Medical Center Foundation, a position she held since 1999, and brin …
Novartis Know Now: Knowing Rose’s BRAF Status Helped Her Find the Best Course of Treatment
October 27, 2020Meet Rose Manbachi – a melanoma survivor who benefited from knowing her BRAF status early on, changing the course of treatment. Learn more about Rose’s story and why it was important for her to Know Now and get tested for the BRAF gene mutation in her …
#EyeGetDilated: Mark Weinzierl
October 20, 2020Guest blog post by Mark Weinzierl, OM survivor and MRF Board Member: My name is Mark Weinzierl and for the last 14 years I have been a survivor of a rare cancer that affects your eyes called ocular melanoma (OM). Although it is in the melanoma family, …
Novartis Know Now: Knowing Deborah’s BRAF Status Saved Her Valuable Time
October 7, 2020Meet Deborah Wassertzug – a melanoma survivor who benefited from knowing her BRAF status early on, changing the course of treatment. Learn more about Deborah’s story and why it was important for her to Know Now and get tested for the BRAF gene mutation …
2020 Research Awards Announced
October 5, 2020For more than 20 years, the MRF had advanced the field of melanoma science by supporting researchers studying a broad scientific agenda covering prevention, diagnosis, staging and treatment. This month we are proud to announce the recipients of 2020 Re …
Recent Comments